Author | Keith Loria


New Drugs Take Aim at Autoimmune Diseases

July 31, 2020


Potential agents to battle inflammation and other processes move through development pipeline.

Biosimilars Fan Club Includes Free-Market Conservatives

July 06, 2020


Pacific Research Institute’s Winegarden Sees Dose of Competition as Way to Lower OOP Costs

Survey: Rheumatologists Still Reluctant to Switch Patients to Biosimilars

July 02, 2020


Cardinal Health recently conducted a survey of more than 100 rheumatologists asking their feelings about biosimilars, and the findings revealed that the majority of them were familiar with and comfortable prescribing biosimilars. 

Q&A With Don McDaniel

July 01, 2020


The veteran healthcare executive says this may be a Netflix vs. Blockbuster moment for hospitals. And health plans may be under pressure to meet the statutory levels for medical spending and recontract with their networks to offer enhanced payments in return for clinical improvement activities.